The tech industry has experienced remarkable growth over the last several years, especially this last year. Due to its rapid innovation, it is one of the most popular industries, attracting retail and institutional investors alike. The benchmark ETF for tracking overall information technology is The Technology Select Sector SPDR Fund (NYSEARCA:XLK), which has increased by
0 Comments
Meta Platforms (NASDAQ:META) is still losing billions of dollars on the metaverse. In fact, in the company’s latest earnings call, CEO Mark Zuckerberg spent a good deal of time talking about how Meta loses money, including the $3.8 billion it lost on the metaverse. Still, Zuckerberg isn’t giving up on the metaverse just yet, which is creating
0 Comments
The stock market provides discerning investors with the opportunity to build wealth. Growth stocks set to surge represent companies expected to expand their earnings and revenue faster than their industry or the overall market.  These companies often reinvest their profits into developing new products and services or growth through acquisitions. Growth stocks are often associated
0 Comments
The stock market has been on an incredible run over the past year with tech and growth stocks surging. Traders have piled into many fast-moving companies in hopes of locking in quick trading gains. This excitement has increasingly moved back into the meme stock arena as well. While meme stocks somewhat fell out of fashion in 2022 and 2023, they are firmly back
0 Comments
Investing in blockchain through cryptocurrencies is incredibly risky. The bulls will quickly point out that Bitcoin (BTC-USD) has delivered an earth-shattering return of more than 14,600% in the past decade. However, if we narrow the time horizon to 3 years, BTC has actually underperformed the S&P 500. Hence, despite the dazzling returns, BTC’s wild price swings have
0 Comments
From its stellar performance in 2021 to deflating in 2022, the biotech sector continued its stagnation into 2023, highlighting some pharma stocks to avoid. Year-to-date, the S&P Biotechnology Select Industry Index has dropped by 4%. Likewise, the number of biotech firms shrunk by 3% in 2023. Although overlapping with the biotech sector, pharma stocks have
0 Comments
Investing in stocks priced under $50 can be attractive for several reasons. Firstly, these stocks are more affordable, allowing investors to purchase more shares with less money. This can provide diversification and the potential for greater returns if the stock price rises. Secondly, lower-priced stocks can generate higher percentage returns as even small price movements
0 Comments
It’s fair to assert that EV stalks are dangerous overall. The sector has been maligned throughout 2024 and continues to face ongoing issues. The electric vehicle industry continues to evolve but is facing what can optimistically be called a rough patch. Thus, many investors would classify any and all EV stocks as being dangerous. Yet, as with any sector, there are bound to be
0 Comments